JP2008519814A5 - - Google Patents

Download PDF

Info

Publication number
JP2008519814A5
JP2008519814A5 JP2007540715A JP2007540715A JP2008519814A5 JP 2008519814 A5 JP2008519814 A5 JP 2008519814A5 JP 2007540715 A JP2007540715 A JP 2007540715A JP 2007540715 A JP2007540715 A JP 2007540715A JP 2008519814 A5 JP2008519814 A5 JP 2008519814A5
Authority
JP
Japan
Prior art keywords
alkyl
heteroaryl
aryl
alkoxy
nr4r5
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2007540715A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008519814A (ja
Filing date
Publication date
Priority claimed from GB0425026A external-priority patent/GB0425026D0/en
Application filed filed Critical
Priority claimed from PCT/GB2005/004358 external-priority patent/WO2006051311A1/en
Publication of JP2008519814A publication Critical patent/JP2008519814A/ja
Publication of JP2008519814A5 publication Critical patent/JP2008519814A5/ja
Abandoned legal-status Critical Current

Links

JP2007540715A 2004-11-12 2005-11-11 プロテインキナーゼ酵素の活性部位と結合する窒素複素環式芳香族化合物 Abandoned JP2008519814A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0425026A GB0425026D0 (en) 2004-11-12 2004-11-12 Compounds which bind to the active site of protein kinase enzymes
GBGB0500245.6A GB0500245D0 (en) 2004-11-12 2005-01-07 Compounds which bind to the active site of protein kinase enzymes
PCT/GB2005/004358 WO2006051311A1 (en) 2004-11-12 2005-11-11 Nitrogen heteroaromatic compounds which bind to the active site of protein kinase enzymes

Publications (2)

Publication Number Publication Date
JP2008519814A JP2008519814A (ja) 2008-06-12
JP2008519814A5 true JP2008519814A5 (cg-RX-API-DMAC7.html) 2008-12-25

Family

ID=35788166

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007540715A Abandoned JP2008519814A (ja) 2004-11-12 2005-11-11 プロテインキナーゼ酵素の活性部位と結合する窒素複素環式芳香族化合物

Country Status (4)

Country Link
EP (1) EP1814856A1 (cg-RX-API-DMAC7.html)
JP (1) JP2008519814A (cg-RX-API-DMAC7.html)
CA (1) CA2585490A1 (cg-RX-API-DMAC7.html)
WO (1) WO2006051311A1 (cg-RX-API-DMAC7.html)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101253152A (zh) * 2005-09-02 2008-08-27 安斯泰来制药株式会社 作为rock抑制剂的酰胺衍生物
CA2660560A1 (en) * 2006-08-16 2008-02-21 Boehringer Ingelheim International Gmbh Pyrazine compounds, their use and methods of preparation
US8071779B2 (en) 2006-12-18 2011-12-06 Inspire Pharmaceuticals, Inc. Cytoskeletal active rho kinase inhibitor compounds, composition and use
EA015952B1 (ru) 2007-05-03 2011-12-30 Пфайзер Лимитед 2-пиридинкарбоксамидные производные в качестве модуляторов натриевых каналов
AU2008289037B2 (en) 2007-08-22 2012-03-01 Novartis Ag 5- (4- (haloalkoxy) phenyl) pyrimidine-2-amine compounds and compositions as kinase inhibitors
TWI504395B (zh) 2009-03-10 2015-10-21 Substituted 3-amino-2-mercaptoquinoline as a KCNQ2 / 3 modifier
TWI461197B (zh) 2009-03-12 2014-11-21 2-mercaptoquinoline-3-carboxamide as a KCNQ2 / 3 modifier
TWI475020B (zh) 2009-03-12 2015-03-01 The substituted nicotine amide as a KCNQ2 / 3 modifier
TW201038565A (en) 2009-03-12 2010-11-01 Gruenenthal Gmbh Substituted 2-mercapto-3-aminopyridines as KCNQ2/3 modulators
ES2459468T3 (es) * 2009-05-15 2014-05-09 Novartis Ag Arilpiridinas como inhibidores de aldosterona sintasa
CN102625804B (zh) * 2009-06-12 2015-04-08 Abivax公司 用于治疗aids的化合物
US10253020B2 (en) 2009-06-12 2019-04-09 Abivax Compounds for preventing, inhibiting, or treating cancer, AIDS and/or premature aging
ES2579949T3 (es) 2010-02-05 2016-08-17 Heptares Therapeutics Limited Derivados de 1,2,4-triazin-4-amina
JP5605727B2 (ja) 2010-04-06 2014-10-15 Jnc株式会社 セレンテラジン類縁体及びセレンテラミド類縁体
KR20130100300A (ko) 2010-08-27 2013-09-10 그뤼넨탈 게엠베하 Kcnq2/3 조절제로서의 치환된 2-옥시-퀴놀린-3-카복스아미드
MX2013000748A (es) 2010-08-27 2013-03-05 Gruenenthal Gmbh 2-amino-quinolina-3-carboxamidas sustituidas como moduladores de kcnq2/3.
PL2609086T3 (pl) 2010-08-27 2015-07-31 Gruenenthal Gmbh Podstawione 2-okso- i 2-tiookso-dihydrochinolino-3-karboksyamidy jako modulatory KCNQ2/3
BR112013005056A2 (pt) 2010-09-01 2016-05-31 Gruenenthal Gmbh 1-oxo-di-hidroisoquinolina-3-carboxamidas substituídas como moduladores kcnq2/3
CA2816679A1 (en) * 2010-11-17 2012-05-24 Novartis Ag 3-(aminoaryl)-pyridine compounds
AU2013222345B2 (en) 2012-02-22 2017-09-07 Sanford-Burnham Medical Research Institute Sulfonamide compounds and uses as TNAP inhibitors
EP2757161A1 (en) 2013-01-17 2014-07-23 Splicos miRNA-124 as a biomarker of viral infection
JP5557408B1 (ja) 2013-04-24 2014-07-23 国立大学法人九州大学 眼底疾患治療剤
WO2015108881A1 (en) 2014-01-14 2015-07-23 Millennium Pharmaceuticals, Inc. Heteroaryls and uses thereof
TN2016000270A1 (en) 2014-01-14 2017-10-06 Millennium Pharm Inc Heteroaryls and uses thereof.
EP2974729A1 (en) 2014-07-17 2016-01-20 Abivax Quinoline derivatives for use in the treatment of inflammatory diseases
WO2017007755A1 (en) 2015-07-06 2017-01-12 Rodin Therapeutics, Inc. Heterobicyclic n-aminophenyl-amides as inhibitors of histone deacetylase
HUE057041T2 (hu) 2015-07-06 2022-04-28 Alkermes Inc Hiszton deacetiláz hetero-halogén gátlói
US12048761B2 (en) 2015-10-13 2024-07-30 Inserm (Institut National De La Santé Et De La Recherche Medicale) Methods and pharmaceutical compositions for the treatment of retinal capillary non-perfusion
EP3484528B1 (en) 2016-07-18 2020-11-25 Janssen Pharmaceutica NV Tau pet imaging ligands
HRP20220223T1 (hr) 2017-01-11 2022-04-29 Alkermes, Inc. Biciklički inhibitori histon deacetilaze
US11225475B2 (en) 2017-08-07 2022-01-18 Alkermes, Inc. Substituted pyridines as inhibitors of histone deacetylase
US11066404B2 (en) 2018-10-11 2021-07-20 Incyte Corporation Dihydropyrido[2,3-d]pyrimidinone compounds as CDK2 inhibitors
EP3669873A1 (en) 2018-12-20 2020-06-24 Abivax Quinoline derivatives for use ine the traeatment of inflammation diseases
WO2020150473A2 (en) 2019-01-18 2020-07-23 Dogma Therapeutics, Inc. Pcsk9 inhibitors and methods of use thereof
BR112021013924A2 (pt) 2019-01-18 2021-09-21 Astrazeneca Ab Inibidores de pcsk9 e métodos de uso do mesmo
WO2020168197A1 (en) 2019-02-15 2020-08-20 Incyte Corporation Pyrrolo[2,3-d]pyrimidinone compounds as cdk2 inhibitors
TW202100520A (zh) 2019-03-05 2021-01-01 美商英塞特公司 作為cdk2 抑制劑之吡唑基嘧啶基胺化合物
US11919904B2 (en) 2019-03-29 2024-03-05 Incyte Corporation Sulfonylamide compounds as CDK2 inhibitors
WO2020223558A1 (en) 2019-05-01 2020-11-05 Incyte Corporation Tricyclic amine compounds as cdk2 inhibitors
WO2020223469A1 (en) 2019-05-01 2020-11-05 Incyte Corporation N-(1-(methylsulfonyl)piperidin-4-yl)-4,5-di hydro-1h-imidazo[4,5-h]quinazolin-8-amine derivatives and related compounds as cyclin-dependent kinase 2 (cdk2) inhibitors for treating cancer
WO2021030537A1 (en) 2019-08-14 2021-02-18 Incyte Corporation Imidazolyl pyrimidinylamine compounds as cdk2 inhibitors
CR20220170A (es) 2019-10-11 2022-10-10 Incyte Corp Aminas bicíclicas como inhibidoras de la cdk2
US11981671B2 (en) 2021-06-21 2024-05-14 Incyte Corporation Bicyclic pyrazolyl amines as CDK2 inhibitors
US11976073B2 (en) 2021-12-10 2024-05-07 Incyte Corporation Bicyclic amines as CDK2 inhibitors
EP4626878A1 (en) 2022-12-02 2025-10-08 Neumora Therapeutics, Inc. Methods of treating neurological disorders
PY2404093A (es) * 2023-01-30 2024-10-03 Eurofarma Laboratorios S A Hidrazidas bloqueadoras de nav 1.7 y/o nav 1.8, sus procesos de obtención, composiciones, usos, métodos de tratamiento de los mismos y kits
WO2025224050A1 (en) 2024-04-22 2025-10-30 Institut National de la Santé et de la Recherche Médicale Methods of treatment of patients suffering from hypomelanosis of ito

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA02002559A (es) * 1999-09-10 2002-07-30 Merck & Co Inc Inhibidores de tirosina cinasa.
DK1330452T3 (da) * 2000-09-20 2009-03-16 Ortho Mcneil Janssen Pharm Pyrazinderivater som modulatorer af tyrosinkinaser
CA2486183C (en) * 2002-05-23 2012-01-10 Cytopia Pty Ltd. Protein kinase inhibitors
EP1644365A2 (en) * 2003-07-02 2006-04-12 Biofocus Discovery Ltd Pyrazine and pyridine derivatives as rho kinase inhibitors

Similar Documents

Publication Publication Date Title
JP6697074B2 (ja) ヒストン脱アセチル化酵素6阻害剤としてのオキサジアゾールアミン誘導体化合物及びこれを含有する薬剤学的組成物
JP5697163B2 (ja) 置換された3−ヒドロキシ−4−ピリドン誘導体
JP7541302B2 (ja) Rnaウィルス感染を処置する為のアリール-n-アリール誘導体
AU757747B2 (en) 4-aroyl-piperidin-CCR-3 receptor antagonists III
TW200909400A (en) Novel sulfonyl malonamide derivative and pharmaceutical use thereof
EP1656351B1 (en) Process for preparation of 4-aryl-nicotinamide derivatives
WO2014069510A1 (ja) 新規アミン誘導体またはその塩
JP4191826B2 (ja) 新規なピペラジン及びピペリジン化合物
EP2346850A1 (en) A method for the preparation of dabigatran and its intermediates
AU2016304769B2 (en) CGRP receptor antagonists
JP2009539938A5 (cg-RX-API-DMAC7.html)
WO2005066164A1 (en) Opioid receptor antagonists
JP2024053563A (ja) Rnaウィルス感染を処置する為のフェニル-n-キノリン誘導体
AU2007251663B2 (en) 4-[(3-fluorophenoxy)phenylmethyl]piperidine methanesulfonate: uses, process of synthesis and pharmaceutical compositions
JP2008508309A (ja) ピリドンカルボン酸抗菌薬の調製
JPH05213872A (ja) メタノアントラセン化合物、該化合物を含有する精神病治療用医薬調剤および上記化合物の製造方法ならびに中間体
CN1863791A (zh) {2-[1-(3,5-双-三氟甲基-苄基)-5-吡啶-4-基-1h-[1,2,3]三唑-4-基]-吡啶-3-基}-(2-氯苯基)-甲酮的新晶形
HUE025163T2 (en) New compounds that are histamine H3 receptor ligands
CN1277611A (zh) 3-取代的四氢吡啶并嘧啶酮衍生物,它们的制备方法和应用
JP2003064057A (ja) フェニルピリジン誘導体
TW200303751A (en) Preparation of N1-(2'-pyridyl)-1, 2-propanediamine sulfamic acid and its use in the synthesis of biologically active piperazines
CN1185153A (zh) 苯并吡喃类化合物和含有它们的药物组合物
JP2013521308A (ja) 2−(シクロヘキシルメチル)−n−{2−[(2s)−1−メチルピロリジン−2−イル]エチル}−1,2,3,4−テトラヒドロイソキノリン−7−スルホンアミドの製造方法
JP2008508250A5 (cg-RX-API-DMAC7.html)
JP2012513993A5 (cg-RX-API-DMAC7.html)